Summary
A systematic search has been used to derive a hypothesis for the receptor-bound conformation of A-II antagonists at the AT1 receptor. The validity of the pharmacophore hypothesis has been tested using CoMFA, which included 50 diverse A-II antagonists, spanning four orders of magnitude in activity. The resulting cross-validated R2 of 0.64 (conventional R2 of 0.76) is indicative of a good predictive model of activity, and has been used to estimate potency for a variety of non-peptidyl antagonists. The structural model for the non-peptide has been compared with respect to the natural substrate, A-II, by generating peptide to non-peptide overlays.
Similar content being viewed by others
References
Vallotton, M.B., Trends Pharmacol. Sci., 8 (1987) 69.
Bovy, P.R. and Baline, E.H., Curr. Cardiovasc. Patents, 1 (1989) 2044.
Turker, R.K., Hall, M.M., Yamamoto, M., Sweet, C.S. and Bumpus, F.M., Science, 177 (1972) 1203.
Hall, M.M., Khosla, M.C., Kairallah, P. and Bumpus, F.M., J. Pharmacol. Exp. Ther., 188 (1974) 222.
Duncia, J.V., Chiu, A.T., Carini, D.J., Gregory, G.B., Johnson, A.L., Price, W.A., Wells, G.J., Wong, P.C., Calabrese, J.C. and Timmermans, P.B.M.W.M., J. Med. Chem., 33 (1990) 1312.
Christen, Y., Waeber, B., Nussberger, J., Porchet, M., Lee, R.J., Maggon, K., Timmermans, P.B.M.W. and Brunner, H.R., J. Hypertens., 8 (1990) S16.
Christen, Y., Waeber, B., Nussberger, J., Porchet, M., Borland, R.M., Lee, R.J., Maggon, K., Shum, L., Timmermans, P.B.M.W. and Brunner, H.R., Circulation, 83 (1991) 1333.
Underwood, D.J., Strader, C., Rivero, R., Patchett, A.A., Greenlee, W.J. and Prendergast, K., (1994) manuscript in preparation.
Mayer, D., Naylor, C.B., Motoc, I. and Marshall, G.R., J. Comput. Aided Mol. Design, 1 (1987) 3.
CramerIII, R.D., Patterson, D.E. and Bunce, J.D., J. Am. Chem. Soc., 110 (1988) 5959.
DePriest, S.A., Mayer, D., Naylor, C.B. and Marshall, G.R., J. Am. Chem. Soc., 115 (1993) 5372.
Duncia, J.V., Carini, D.J., Chiu, A.T., Johnson, A.L., Price, W.A., Wong, P.C., Wexler, R.R. and Timmermans, P.B.M.W., Med. Res. Rev., 12 (1992) 149.
Lin, H., Rampersaud, A., Zimmerman, K., Steinberg, M.I. and Boyd, D.B., J. Med. Chem., 35 (1992) 2658.
Chakravarty, P.K., Camara, V.J., Chen, A., Marcin, L.M., Greenlee, W.J., Patchett, A.A., Chang, R.S., Lotti, V. and Siegl, P.K.S., 200th National Meeting of the American Chemical Society, Washington, DC, August 26–31, 1990.
Rivero, R., Merck Research Laboratories, unpublished work, 1989.
SYBYL, Version 5.2, TRIPOS Associates, St. Louis, MO, 1989.
Ohta, M. and Koga, H., J. Med. Chem., 34 (1991) 131.
Mantlo, N.B., Chakravarty, P.K., Ondeyka, D.L., Siegl, P.K.S., Chang, R.S., Lotti, V.J., Faust, K.A., Chen, T.-B., Schorn, T.W., Sweet, C.S., Emmert, S.E., Patchett, A.A. and Greenlee, W.J., J. Med. Chem., 34 (1991) 2919.
Allen, E.E., deLaszlo, S.E., Huang, S.X., Quagliato, C.S., Greenlee, W.J., Chen, R.T., Faust, K.A. and Lotti, V.J., Bioorg. Med. Chem. Lett., 3 (1993) 1293.
Dhanoa, D., Bagley, S.W., Chang, R.S.L., Lotti, V.J., Siegl, P.K.S., Patchett, A.A. and Greenlee, W.J., 204th National Meeting of the American Chemical Society, Washington, DC, August 23–28, 1992.
Greenlee, W.J., Johnston, D.B.R. and MacCoss, M., U.S. Patent No. 5,157,040, 1992.
Naylor, E.M., Chakravarty, P.K., Chen, A., Strelitz, R.A., Chang, R.S., Chen, T.B., Faust, K.A., Lotti, V.J., Kivlighn, S.D., Zingaro, G.J., Schorn, T.W., Siegl, P.K.S., Patchett, A.A. and Greenlee, W.J., 206th National Meeting of the American Chemical Society, Chicago, IL, August 22–27, 1993.
Fitch, K.J., Walsh, T.F., Patchett, A.A., Chang, R.S.L. and Greenlee, W.J., 205th National Meeting of the American Chemical Society, Denver, CO, March 28-April 2, 1993.
Ondeyka, D.L., Mantlo, N.B., Chakravarty, P.K., Chen, A., Camara, V.J., Chang, R.S.L., Lotti, V.J., Siegl, P.K.S., Patchett, A.A. and Greenlee, W.J., Joint Central-Great Lakes Regional Meeting of the American Chemical Society, Indianapolis, IN, May 31, 1991.
Kevin, N.J., Rivero, R.A., Greenlee, W.J. and Chang, R.S., 205th National Meeting of the American Chemical Society, Denver, CO, March 28-April 2, 1993.
Ashton, W.T., Cantone, C.L., Chang, L.L., Hutchins, S.M., Strelitz, R.A., MacCoss, M. Chang, R.S.L., Lotti, V.J., Faust, K.A., Chen, T.-B., Bunting, P., Schorn, T.W., Kivlighn, S.D. and Siegl, P.K.S., J. Med. Chem., 36 (1993) 591.
Chang, L.L., Ashton, W.T., Flanagan, K.L., Strelitz, R.A., MacCoss, M., Greenlee, W.J., Chang, R.S.L., Lotti, V.J., Faust, K.A., Chen, T.B., Bunting, P., Zingaro, G.J., Kivlighn, S.D. and Siegl, P.K.S., J. Med. Chem., 36 (1993) 2558.
Allen, E., Merck Research Laboratories, unpublished work, 1989.
Allen, E.E., Greenlee, W.J., Chakravarty, P.K., Patchett, A.A. and Walsh, T.F., U.S. Patent No. 5,100,897, 1992.
OPTIMOL contains the MM2X force field, which differs from MM2 principally in that electrostatic interactions take place between atom-centered charges. The atomic charges (q) are derived from the bond dipole moments (μ): q = (1/4.803) Σi μi r0i. Here, r0 is the reference bond length. This is the only difference in the functional form of MM2X with respect to MM2 [15]. Parameters for the nonbond out of plane and stretch-bend interactions are taken directly from MM2. MM2X does not use lone pairs on aliphatic amines, ether oxygens, and carboxylic acid and ester oxygens, and any parameterization differences are primarily due to the need to make up this difference. OPTIMOL has been developed at Merck Research Laboratories by T.A. Halgren and other members of the Molecular Systems Department [16].
Allinger, N.L., J. Am. Chem. Soc., 99 (1977) 8127.
Halgren, T.A., J. Am. Chem. Soc., 114 (1992) 7827.
The MM2 force field, as supplied with Batchmin (Still, W.C., Mohamadi, F., Richards, N.J.G., Guida, W.C., Liskamp, R., Lipton, M., Caufield, C., Chang, G. and Hendrickson, T., MACROMODEL, Version 4.0, Department of Chemistry, Columbia University, New York, NY), was used with the following supplemental parameters: N2*N2 bonds were set at 1.326 Å and.7.72 mdyn/Å2; N2*C2*N2 angles were set at 128° and 0.96 mdyn/rad2; *N2* angles were set at 123° and 0.7 mdyn/rad2; and C2*C2*C3*N2 and O3*C2*C3*N2 torsions both have their V2 terms set at 0.7 kcal/mol. C2*S1*N2*C3 torsions were set at V1=2.805 kcal/mol, V2=−1.133 kcal/mol and V3=−0.621 kcal/mol, while N3*S1*N2A*C3 torsions were set at V1=0 kcal/mol, V2=1.133 kcal/mol, and V3=0.621 kcal/mol. An external angle description for azinoid and pyridinoid fragments (N2*AA*AA*AA*AA*, N2*AA*AA*AA*AA*AA*) was added as 122.5°, with a force constant of 0.5 mdyn/Å2.
SYBYL, Version 5.32, TRIPOS Associates, St. Louis, MO, 1990.
Dewar, M.J.S. and Thiel, W., J. Am. Chem. Soc., 99 (1977) 4899.
Chakravarty, P.K., Greenlee, W.J., Mantlo, N.B., Patchett, A.A. and Walsh, T.F., European Patent Application 400,974, 1990.
Chakravarty, P.K., Patchett, A.A., Camara, V.J., Walsh, T.F. and Greenlee, W.J., European Patent Application 400,835, 1990.
Allen, E.E., Greenlee, W.J., MacCoss, M. and Patchett, A.A., U.S. Patent No. 5,166,206, 1992.
Mantlo, N.B., Ondeyka, D., Chang, R.S.L., Lotti, V.J., Kivlighn, S.D., Siegl, P.K.S., Patchett, A.A. and Greenlee, W.J., 202nd National Meeting of the American Chemical Society, New York, NY, September 5–10, 1991.
Bagley, S., Greenlee, W.J., Dhanoa, D.S. and Patchett, A.A., U.S. Patent No. 5,175,164, 1992.
Allen, E.E., Huang, S.X., Chang, R.S.L., Lotti, V.J., Siegl, P.K.S., Patchett, A.A. and Greenlee, W.J., 202nd National Meeting of the American Chemical Society, New York, NY, August 25–30, 1991.
Patchett, A.A., Mantlo N.B. and Greenlee, W.J., U.S. Patent No. 5,124,335, 1992.
Glinka, T.W., de Laszlo, S.E., Siegl, P.K.S., Chang, R.S.L., Kivlighn, S.D., Schorn, T.S., Faust, K.A., Chen, T.B., Zingaro, G.J., Lotti, V.J. and Greenlee, W.J., Bioorg. Med. Chem. Lett., 4 (1994) 81.
Chakravarty, P.K., Strelitz, R.A., Chen, T.-B., Chang, R.S.L., Lotti, V.J., Zingaro, G.J., Schorn, T.W., Kivlighn, S.D., Siegl, P.K.S., Patchett, A.A. and Greenlee, W.J., Bioorg. Med. Chem. Lett., 4 (1994) 75.
Chakravarty, P.K., Merck Research Laboratories, unpublished work, 1990.
Allen, E., deLaszlo, S.E., Greenlee, W.J., Patchett, A.A., Chakravarty, P.K. and Walsh, T.F., European Patent Application EP-411, 766, 1990.
Greenlee, W.J., Johnston, D.B.R., MacCoss, M., Mantlo, N.B., Patchett, A.A., Chakravarty, P.K. and Walsh, T.F., U.S. Patent No. 5,164,407, 1992.
Kevin, N.J., Rivero, R.A. and Greenlee, W.J., 202nd National Meeting of the American Chemical Society, New York, NY, August 25–30, 1991.
Walsh, T., Merck Research Laboratories, unpublished work, 1989.
Ashton, W.T., Hutchins, S.M., Greenlee, W.J., Doss, G.A., Chang, R.S.L., Lotti, V.J., Faust, K.A., Chen, T.-B., Zingaro, G.J., Kivlighn, S.D. and Siegl, P.K.S., J. Med. Chem., 36 (1993) 3595.
Kearsley, S.K. and Smith, G.H., Tetrahedron Comput. Methodol., 3 (1990) 615.
Adams, K., Merck Research Laboratories, unpublished work, 1991.
Bradbury, R.H., Allot, C.P., Dennis, M., Fisher, E., Major, J.S., Masek, B.B., Oldham, A.A., Pearce, R.J., Rankine, N., Revill, J.M., Roberts, D.A. and Russell, S.T., J. Med. Chem., 35 (1992) 4027.
Masek, B.B., Merchant, A. and Matthew, J.B., J. Med. Chem., 36 (1993) 1230.
Perkins, T.D.J. and Dean, P.M., J. Comput.-Aided Mol. Design, 7 (1993) 155.
Thomas, A.P., Allott, C.P., Gibson, K.H., Major, J.S., Masek, B.B., Oldham, A.A., Ratcliffe, A.H., Roberts, D.A., Russell, S.T. and Thomason, D.A., J. Med. Chem., 35 (1992) 877.
Martin, Y.C., Bures, M.G., Danaher, E.A., De Lazzer, J., Lico, I. and Pavlik, P.A., J. Comput.-Aided Mol. Design, 7 (1993) 83.
Crippen, G. and Havel, T.F., Acta Crystallogr., A34 (1987) 282.
DGEOM, written by J.D. Andose, Merck Research Laboratories, 1992.
Buehlmayer, P., Criscione, L., Fuhrer, W., Furet, P., di Gaspous, M., Sturtz, S. and Whitebread, S., J. Med. Chem., 34 (1991) 3105.
Wong, P.C., PriceJr., W.A., Chiu, A.T., Thoolen, M.J.M.C., Duncia, J.V., Johnson, A.L. and Timmermans, P.B.M.W.M., Hypertension, 13 (1989) 489.
Chiu, A.T., McCall, D.E., Price, W.A., Wong, P.C., Carini, D.J., Duncia, J.V., Wexler, R.R., Yoo, S.E., Johnson, A.L. and Timmermans, P.B.M.W.M., J. Pharmacol. Exp. Ther., 252 (1990) 711.
Bradbury, R.H., Allott, C.P., Girdwood, J.A., Kenny, P.W., Major, J., Oldham, A.A., Ratcliffe, A.H., Rivett, J.E., Roberts, D.A. and Robins, P.J., J. Med. Chem., 36 (1993) 1245.
Kearsley, S.K., Sallamack, S., Sheridan, R.P., Fluder, E.M. and Andose, J.D., J. Chem. Inf. Comput. Sci., in press.
Mantlo, N.B., Chakravarty, P.K., Ondeyka, D.L., Siegl, P.K.S., Chang, R.S., Lotti, V.S., Faust, K.A., Chen, T.B., Schorn, T.W., Sweet, C.S., Emment, S.E., Patchett, A.A. and Greenlee, W.J., J. Med. Chem., 34 (1990) 2919.
Weinstock, J., Keenan, R.M., Samanen, J., Hempel, J., Finkelstein, J.A., Franz, R.G., Gaitanopolos, D.E., Girard, G.R., Gleason, J.G., Hill, D.T., Morgan, T.M., Peishoff, C.E., Aiyar, A., Brooks, D.P., Fredrickson, T.A., Ohlstein, E.H., Ruffalo, R.R., Stank, E.J., Sulpizio, A.C., Weidley, E.F. and Edwards, R.M., J. Med. Chem., 34 (1991) 1514.
Samanen, J.M., Peishoff, C.E., Keenan, R.M. and Weinstock, J., Bioorg. Med. Chem. Lett., 3 (1993) 909.
Smeby, R.R. and Fermandjian, S., In Weinstein, B. (Ed.) Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins, Marcel Dekker, New York, NY, 1978, pp. 117–162.
Moore, G.J., Int. J. Pept. Protein Res., 26 (1985) 469.
Turner, R.J., Matsoukas, J.M. and Moore, G.J., Biochem. Biol. Acta, 1065 (1991) 21.
Sugg, E.E., Dolan, C.A., Patchett, A.A., Chang, R.S.L., Faust, K.A. and Lotti, V., In Rivier, J.E. and Marshall, G.R. (Eds.) Peptides: Chemistry, Structure and Biology (Proceedings of the 11 th American Peptide Symposium), ESCOM, Leiden, 1990, pp. 305–306.
Kataoka, T., Beuser, D.D., Clark, J.D., Yodo, M. and Marshall, G.R., Biopolymers, 32 (1992) 1519.
Samanen, J., Cash, T., Narindray, D. and Brandeis, E., J. Med. Chem., 34 (1992) 3036.
Juvvadi, P., Dooley, D.J., Humblet, C.C., Lu, G.H., Lunney, E.A., Panek, R.L., Skeean, R. and Marshall, G.R., Int. J. Pept. Protein Res., 40 (1992) 163.
Spear, K.L., Brown, M.S., Reinhard, E.J., McMahon, E.G., Olins, G.M., Palema, M.A. and Patta, D.R., J. Med. Chem., 33 (1990) 1935.
Pierson, M.E. and Freer, R.J., Pept. Res., 5 (1992) 102.
Plucinska, K., Kataoka, T., Yodo, M., Cody, W.L., He, J.X., Humblet, C., Lu, G.H., Lunney, E., Major, T.C., Panek, R.L., Schelkun, P., Skeean, R. and Marshall, G.R., J. Med. Chem., 36 (1993) 1902.
Nikiforovich, G.V. and Marshall, G.R., Biochem. Biophys. Res. Commun., 195 (1993) 222.
Bush, B.L. and Nachbar, R.B., J. Comput.-Aided Mol. Design, 7 (1993) 587.
Gether, U., Johansen, T.E., Snider, R.M., Lowe, J.A., Nakanishi, S. and Schwartz, T.W., Nature, 352 (1993) 345.
Casciere, M., Macleod, A.M., Underwood, D., Shiao, L., Ber, E., Sadowski, S., Yu, H., Merchant, K.J., Swain, C.J., Strader, C.D. and Fong, T.M., J. Biol. Chem., 269 (1994) 6587.
Sachais, B., Snider, R.M., Lowe, J.A. and Krause, J.E., J. Biol. Chem., 268 (1992) 2319.
Jensen, C.J., Gerard, N.P., Schwartz, T.W. and Gether, U., Mol. Pharmacol., 45 (1994) 294.
Huang, R.C., Yu, H., Strader, C.D. and Fong, T.M., Biochemistry, 33 (1994) 3007.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prendergast, K., Adams, K., Greenlee, W.J. et al. Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor. J Computer-Aided Mol Des 8, 491–512 (1994). https://doi.org/10.1007/BF00123662
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00123662